King Ups Medicaid Rebate Underpayment Estimate To $65 Mil.; CEO To Depart

King Pharmaceuticals is raising its estimated Medicaid rebate underpayments by $18.9 mil. to $65.4 mil. following the completion of an internal audit, CFO Jim Lattanzi said during a Feb. 19 conference call